Coronavirus vaccination: US approves vaccine for children

Image copyright US Food and Drug Administration Image caption A vaccination against the virus has been given the green light by the FDA A children’s Coronavirus vaccine produced by Pfizer has been given the…

Coronavirus vaccination: US approves vaccine for children

Image copyright US Food and Drug Administration Image caption A vaccination against the virus has been given the green light by the FDA

A children’s Coronavirus vaccine produced by Pfizer has been given the go-ahead by the US Food and Drug Administration (FDA).

Coronavirus is related to the H5N1 bird flu virus.

The vaccine is aimed at young children aged two to 14 years old, and will be made available to US healthcare providers from late September.

Pfizer, which is owned by global pharmaceutical giant Pfizer, said any parents currently taking precaution against the virus would still have a choice over whether to vaccinate their children.

Coronavirus was first found in people in 2003 and is most commonly found in respiratory diseases caused by the H5N1 strain of bird flu.

Two serious human pandemics, in 1957 and 1968, were caused by H5N1, and the virus is present in mammals as well.

Children’s Coronavirus vaccination

Image copyright US Food and Drug Administration Image caption The vaccination will be made available to the US healthcare provider market by late September

The US FDA said the vaccine, which is made using modified HIV strains, is effective in adults and young children.

The agency added that the vaccine’s safety evaluation included more than 600 children from five different countries.

Children’s Coronavirus vaccination

Image copyright US Food and Drug Administration Image caption The vaccine is manufactured using modified HIV strains

Drug giant Pfizer said it planned to manufacture two doses of the vaccine, initially, for the US healthcare market by the end of September.

If the vaccine is purchased by healthcare providers, Pfizer said their intended usage would be three doses, for two years following the first dose.

In early 2017, the FDA gave permission for Japan to begin trial studies on a children’s Coronavirus vaccine in consideration of the H5N1 virus.

Image copyright US Food and Drug Administration Image caption Japan has begun clinical trials on a Coronavirus vaccine produced by GlaxoSmithKline

Britain said it was working to increase understanding of the virus after the Department for Environment, Food and Rural Affairs (Defra) announced the launch of a programme to analyse certain symptoms seen in people with severe influenza.

The aim of the clinical research programme will be to identify any warning signs that could provide early warning signs of H5N1.

“Health protection remains an integral part of Defra’s response to the current outbreak,” the department said.

Leave a Comment